Plasma ALT and AST levels were significantly higher in the AF group compared with the PF group, which can be completely suppressed by NAM treatment (Figure 5L,M), in line with the changes in SA‐β‐gal activity (Figure 5N) and other senescence marker levels (Figure 5B, D–J). The gene discussed is GPT; the disease is atrial fibrillation.